Close

Notable Analyst Rating Changes 3/8: (BMRN) (SHOP) (PNRA) Upgraded; (AN) (SAM) (EPE) Downgraded

March 8, 2016 10:19 AM EST Send to a Friend
UPGRADES
Baird restarts and upgrades BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) from Neutral to Outperform and moves its price target from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login